Share

NIPER Guwahati and Hindustan Antibiotics sign MoU

For large scale industrial grade manufacturing and commercialisation of 3D antimicrobial face-shields to control spread of COVID-19

Share
National Institute of Pharmaceuticals Education and Research, NIPER Guwahati, 3D antimicrobial face-shields, Director Dr U S N. Murty, Hindustan Antibiotic

National Institute of Pharmaceuticals Education and Research (NIPER)-Guwahati is committed to providing a useful contribution cum solution in terms of developing Personal Protective Equipment’s (PPEs) to avoid the fatal spread of COVID-19 transmission. Director Dr U S N. Murty informed that he signed MoU with the Hindustan Antibiotic (HAL), Pimpri, Pune for large scale industrial-grade manufacturing and commercialization of their 3D printed antimicrobial face-shields.

NIPER-Guwahati has also filed both an Indian design patent and provisional patent at Indian Patent Office, New Delhi on their 3D printed antimicrobial face-shields.

NIPER-G has designed, developed & validated 3D-printed antimicrobial face-shield to control the spread of novel coronavirus, after careful analyses of several resources for risk measurement and on how viruses spread through bare hands and other body cavities like oral, ophthalmic & olfactory, etc. (even though ear as well). Some of the salient features of their developed 3D printed antimicrobial face-shields include, highly occlusive, transparent, easy-to-design, low cost, easy to wear, antimicrobial in nature, excellent chemical stability, non-fragile and easy to clean with the existing sanitizers or any alcoholic disinfectant.

Newsletter

Most Popular

Digital Edition

September-2020
From the magazine

Subscribe Now